ResearcherUniversity of VeronaNo recent work listed

Enrico Boninsegna

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7509-6786; OpenAlex author ID A5070000905. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper

Papers 2

Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour attenuation on CT correlates with R0 re… Co-author DOI 10.1007/s00330-018-5410-6 ↗
Paraduodenal pancreatitis as a mimicker of pancreatic adenocarcinoma: MRI evaluation. Co-author DOI 10.1016/j.ejrad.2017.08.031 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Roberto Pozzi Mucelli · 2 shared papers, 2017–2018 · strength 0.16
- Paper Paraduodenal pancreatitis as a mimicker of pancreatic adenocarcinoma: MRI evaluation. DOI 10.1016/j.ejrad.2017.08.031 ↗
- Paper Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour… DOI 10.1007/s00330-018-5410-6 ↗
Giulia Angela Zamboni · 1 shared paper, 2017 · strength 0.08
- Paper Paraduodenal pancreatitis as a mimicker of pancreatic adenocarcinoma: MRI evaluation. DOI 10.1016/j.ejrad.2017.08.031 ↗
Claudio Bassi · 1 shared paper, 2018 · strength 0.08
- Paper Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour… DOI 10.1007/s00330-018-5410-6 ↗
Giovanni Marchegiani · 1 shared paper, 2018 · strength 0.08
- Paper Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour… DOI 10.1007/s00330-018-5410-6 ↗
Roberto Salvia · 1 shared paper, 2018 · strength 0.08
- Paper Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour… DOI 10.1007/s00330-018-5410-6 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.